Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
combination drug
|
| gptkbp:ATCCode |
P01BD51
|
| gptkbp:combines |
gptkb:artesunate
gptkb:amodiaquine |
| gptkbp:contains |
gptkb:sulfadoxine
pyrimethamine |
| gptkbp:contraindication |
severe kidney disease
severe liver disease sulfa allergy |
| gptkbp:discoveredBy |
1960s
|
| https://www.w3.org/2000/01/rdf-schema#label |
sulfadoxine-pyrimethamine
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Fansidar
|
| gptkbp:mechanismOfAction |
inhibits folic acid synthesis in Plasmodium
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:resistanceReported |
yes
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting rash allergic reactions |
| gptkbp:usedFor |
malaria
intermittent preventive treatment in pregnancy intermittent preventive treatment in infants treatment of uncomplicated Plasmodium falciparum malaria |
| gptkbp:WHOModelListOfEssentialMedicines |
yes
|
| gptkbp:bfsParent |
gptkb:Plasmodium_falciparum
|
| gptkbp:bfsLayer |
5
|